TGFB2 and diffuse intrinsic pontine glioma: We compared the survival outcomes of DIPG patients with TGFB2 mRNA expression levels greater than or equal to the upper quartile (TGFB2high) to the treatment outcomes of the remaining DIPG patients (TGFB2low).